Literature DB >> 30806947

Targeting Cell Senescence for the Treatment of Age-Related Bone Loss.

Robert J Pignolo1,2,3, Rebekah M Samsonraj4, Susan F Law4, Haitao Wang4,5,6, Abhishek Chandra4,5,6.   

Abstract

PURPOSE OF REVIEW: We review cell senescence in the context of age-related bone loss by broadly discussing aging mechanisms in bone, currently known inducers and markers of senescence, the senescence-associated secretory phenotype (SASP), and the emerging roles of senescence in bone homeostasis and pathology. RECENT
FINDINGS: Cellular senescence is a state of irreversible cell cycle arrest induced by insults or stressors including telomere attrition, oxidative stress, DNA damage, oncogene activation, and other intrinsic or extrinsic triggers and there is mounting evidence for the role of senescence in aging bone. Cellular aging also instigates a SASP that exerts detrimental paracrine and likely systemic effects. With aging, multiple cell types in the bone microenvironment become senescent, with osteocytes and myeloid cells as primary contributors to the SASP. Targeting undesired senescent cells may be a favorable strategy to promote bone anabolic and anti-resorptive functions in aging bone, with the possibility of improving bone quality and function with normal aging and/or disease.

Entities:  

Keywords:  Aging; Cell senescence; Osteoporosis; Senescence-associated secretory phenotype; Senolytic drug; Telomere dysfunction

Mesh:

Year:  2019        PMID: 30806947     DOI: 10.1007/s11914-019-00504-2

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  218 in total

1.  Senescence and cytoskeleton: overproduction of vimentin induces senescent-like morphology in human fibroblasts.

Authors:  K Nishio; A Inoue; S Qiao; H Kondo; A Mimura
Journal:  Histochem Cell Biol       Date:  2001-10       Impact factor: 4.304

2.  Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent.

Authors:  V V Ogryzko; T H Hirai; V R Russanova; D A Barbie; B H Howard
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

3.  Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer.

Authors:  Andrew E Teschendorff; Usha Menon; Aleksandra Gentry-Maharaj; Susan J Ramus; Daniel J Weisenberger; Hui Shen; Mihaela Campan; Houtan Noushmehr; Christopher G Bell; A Peter Maxwell; David A Savage; Elisabeth Mueller-Holzner; Christian Marth; Gabrijela Kocjan; Simon A Gayther; Allison Jones; Stephan Beck; Wolfgang Wagner; Peter W Laird; Ian J Jacobs; Martin Widschwendter
Journal:  Genome Res       Date:  2010-03-10       Impact factor: 9.043

4.  Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women.

Authors:  C Slemenda; C Longcope; M Peacock; S Hui; C C Johnston
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

5.  False-positive beta-galactosidase staining in osteoclasts by endogenous enzyme: studies in neonatal and month-old wild-type mice.

Authors:  Paul R Odgren; Carole A MacKay; April Mason-Savas; Meiheng Yang; Geneviève Mailhot; Mark J Birnbaum
Journal:  Connect Tissue Res       Date:  2006       Impact factor: 3.417

6.  Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts.

Authors:  D A Alcorta; Y Xiong; D Phelps; G Hannon; D Beach; J C Barrett
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

7.  Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo.

Authors:  Florence Debacq-Chainiaux; Jorge D Erusalimsky; Judith Campisi; Olivier Toussaint
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

8.  Identification of Senescent Cells in the Bone Microenvironment.

Authors:  Joshua N Farr; Daniel G Fraser; Haitao Wang; Katharina Jaehn; Mikolaj B Ogrodnik; Megan M Weivoda; Matthew T Drake; Tamara Tchkonia; Nathan K LeBrasseur; James L Kirkland; Lynda F Bonewald; Robert J Pignolo; David G Monroe; Sundeep Khosla
Journal:  J Bone Miner Res       Date:  2016-10-24       Impact factor: 6.741

9.  The tumor suppressor PML specifically accumulates at RPA/Rad51-containing DNA damage repair foci but is nonessential for DNA damage-induced fibroblast senescence.

Authors:  Sandra Münch; Stefanie Weidtkamp-Peters; Karolin Klement; Paulius Grigaravicius; Shamci Monajembashi; Paolo Salomoni; Pier Paolo Pandolfi; Klaus Weißhart; Peter Hemmerich
Journal:  Mol Cell Biol       Date:  2014-03-10       Impact factor: 4.272

Review 10.  Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity.

Authors:  Allyson K Palmer; Tamara Tchkonia; Nathan K LeBrasseur; Eduardo N Chini; Ming Xu; James L Kirkland
Journal:  Diabetes       Date:  2015-07       Impact factor: 9.461

View more
  13 in total

1.  Kynurenine inhibits autophagy and promotes senescence in aged bone marrow mesenchymal stem cells through the aryl hydrocarbon receptor pathway.

Authors:  Dmitry Kondrikov; Ahmed Elmansi; Robert Tailor Bragg; Tanner Mobley; Thomas Barrett; Nada Eisa; Galina Kondrikova; Patricia Schoeinlein; Alexandra Aguilar-Perez; Xing-Ming Shi; Sadanand Fulzele; Meghan McGee Lawrence; Mark Hamrick; Carlos Isales; William Hill
Journal:  Exp Gerontol       Date:  2019-12-05       Impact factor: 4.032

Review 2.  Exercise to Mend Aged-tissue Crosstalk in Bone Targeting Osteoporosis & Osteoarthritis.

Authors:  Sarah E Little-Letsinger; Janet Rubin; Brian Diekman; Clinton T Rubin; Cody McGrath; Gabriel M Pagnotti; Eric L Klett; Maya Styner
Journal:  Semin Cell Dev Biol       Date:  2021-09-04       Impact factor: 7.727

3.  Senomorphic agent pterostilbene ameliorates osteoarthritis through the PI3K/AKT/NF-κB axis: an in vitro and in vivo study.

Authors:  Yu Wang; Huai Zhao; Shuangshuo Jia; Qian Wang; Wuyi Yao; Yue Yang; Lunhao Bai
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

Review 4.  Activation and Function of NLRP3 Inflammasome in Bone and Joint-Related Diseases.

Authors:  Tomohiko Murakami; Yuri Nakaminami; Yoshifumi Takahata; Kenji Hata; Riko Nishimura
Journal:  Int J Mol Sci       Date:  2022-05-11       Impact factor: 6.208

Review 5.  Osteoporosis and periodontal diseases - An update on their association and mechanistic links.

Authors:  Bo Yu; Cun-Yu Wang
Journal:  Periodontol 2000       Date:  2022-03-04       Impact factor: 12.239

6.  Hedgehog Inhibitors Suppress Osteoclastogenesis in In Vitro Cultures, and Deletion of Smo in Macrophage/Osteoclast Lineage Prevents Age-Related Bone Loss.

Authors:  Yukihiro Kohara; Ryuma Haraguchi; Riko Kitazawa; Yuuki Imai; Sohei Kitazawa
Journal:  Int J Mol Sci       Date:  2020-04-15       Impact factor: 5.923

Review 7.  Bone Aging, Cellular Senescence, and Osteoporosis.

Authors:  Robert J Pignolo; Susan F Law; Abhishek Chandra
Journal:  JBMR Plus       Date:  2021-04-02

8.  Impaired autophagy triggered by HDAC9 in mesenchymal stem cells accelerates bone mass loss.

Authors:  Liqiang Zhang; Meng Qi; Ji Chen; Jiangdong Zhao; Liya Li; Jiachen Hu; Yan Jin; Wenjia Liu
Journal:  Stem Cell Res Ther       Date:  2020-07-03       Impact factor: 8.079

9.  miR-140 Attenuates the Progression of Early-Stage Osteoarthritis by Retarding Chondrocyte Senescence.

Authors:  Hai-Bo Si; Ti-Min Yang; Lan Li; Mei Tian; Li Zhou; Dai-Ping Li; Qiang Huang; Peng-de Kang; Jing Yang; Zong-Ke Zhou; Jing-Qiu Cheng; Bin Shen
Journal:  Mol Ther Nucleic Acids       Date:  2019-11-09       Impact factor: 8.886

10.  Radiation induces primary osteocyte senescence phenotype and affects osteoclastogenesis in vitro.

Authors:  Yuyang Wang; Linshan Xu; Jianping Wang; Jiangtao Bai; Jianglong Zhai; Guoying Zhu
Journal:  Int J Mol Med       Date:  2021-03-11       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.